Researchers have published two papers describing how they identified a potential new pathway for treating a sporadic form of amyotrophic lateral sclerosis (ALS). The studies were published as part of a cooperative research ...
Aug 31, 2022
0
56
Children with congenital heart disease (CHD) often have neurodevelopmental impairment. Until fairly recently, this was thought to stem from complications of cardiac surgery or reduced oxygen supply to the brain due to the ...
Jun 3, 2022
0
5
In a new study of long COVID published March 13, 2022, in the Annals of Neurology, UC San Francisco researchers identified biomarkers present at elevated levels that may persist for many months in the blood of study participants ...
May 27, 2022
0
9
Infantile spasm (IS) is a severe epileptic syndrome of infancy and accounts for 50% of all epilepsy cases that occur in babies during the first year of life. Current treatment options for this disorder are limited and most ...
May 20, 2022
0
12
Life expectancy for individuals with Down syndrome has grown in recent decades, thanks in large part to progress in patient care and treatment. But with survival into the fifth and sixth decades of life now possible, increasing ...
Mar 16, 2022
0
24
Most patients with severe COVID who are put on ventilators regain consciousness after removal of respiratory support, but recovery may take weeks after the period of mechanical ventilation has ended, according to a new study ...
Mar 15, 2022
0
14
Autoimmune diseases are the molecular equivalent of "friendly fire": The body attacks itself instead of harmful invaders. Now, researchers from Japan have found that interrupting the complex interplay between different immune ...
Mar 11, 2022
0
98
A new paper in Annals of Neurology describes the approach, structure, and launch of the HEALEY ALS Platform Trial—the first platform trial for amyotrophic lateral sclerosis (ALS)—designed to accelerate the development ...
Feb 28, 2022
0
20
A University of Calgary study has found promising results for the generic drug hydroxychloroquine when used to treat the evolution of disability of primary progressive multiple sclerosis (MS), the least treatable form of ...
Jan 13, 2022
0
408
Treatments used to help people with multiple sclerosis (MS) manage their condition can reduce the effectiveness of COVID-19 vaccines, according to a new study led by Cardiff University.
Dec 15, 2021
0
90
